| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2024 | Gibson Christopher71 | Chief Executive Officer | Sale+OE | 61,319 | $11.73 | $719,504.90 | - | -25.7% | -44.9% | |
| Mar 5, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $12.06 | $241,805.12 | -0.3% | -27.9% | -44.8% | |
| Feb 22, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 8,000 | $14.90 | $119,160.00 | -1.2% | -37.6% | -38.1% | |
| Feb 20, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $12.32 | $247,124.87 | -0.3% | -22.3% | -13.7% | |
| Feb 14, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $10.16 | $507,984.99 | -4.0% | -8.0% | -22.2% | |
| Feb 7, 2024 | Gibson Christopher71 | Chief Executive Officer | Sale+OE | 48,272 | $9.22 | $444,980.95 | -5.9% | -3.7% | -20.7% | |
| Feb 6, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 11,447 | $9.30 | $106,489.15 | -0.2% | -5.7% | -16.5% | |
| Jan 25, 2024 | Larson Tina Marriott73 | President and COO | Sale+OE10b5-1 | 8,000 | $10.35 | $82,761.60 | -1.9% | -22.4% | -28.3% | |
| Jan 23, 2024 | Borgeson Blake68 | Director | Sell10b5-1 | 20,054 | $10.58 | $212,083.08 | -0.3% | -28.6% | -29.6% | |
| Jan 17, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 50,000 | $10.35 | $517,507.50 | -4.8% | -26.2% | -37.6% |